$CTSHBearishMed

focused firms Astera, CoreWeave in quarterly reshuffle

Nasdaq said Cognizant Technology Solutions will be removed from the Nasdaq-100 effective June 22, ending more than two decades in the index, per its June 2026 quarterly rebalance announcement. Charter Communications, Insmed, Verisk Analytics and Zscaler also exit. Astera Labs, CoreWeave, Nebius Group, Rocket Lab and Teradyne replace them. Cognizant shares fell about 38% in six months, closing at $52.17 on June 12.

7/10
4/10
Med
Bearish
Effective before market opens June 22 (Nasdaq-100 rebalance)
Risk-on tilt toward AI/semiconductor-linked names via index additions; risk-off for removed legacy IT/software names.

Index deletion can drive passive selling/flows and raise near-term liquidity/benchmark-tracking pressure.

Cognizant will be removed from the Nasdaq-100 effective June 22 after more than two decades, following a ~38% stock drop over six months.

Potential short-term downside/volatility into the June 22 effective date due to index-fund rebalancing flows.

Background

Nasdaq-100 quarterly rebalance announced June 11; changes take effect before market open June 22, alongside updated “fast entry” index rules effective May 2026.

Why it matters

Traders can anticipate benchmark-tracking rebalancing flows: deletions (CTSH, CHTR, INSM, VRSN, Z) may face mechanical selling; additions (ASTS, RGTI, NEBI, RKLB, TER) may see mechanical buying. The article also notes Cognizant’s recent ~38% six-month decline, which may interact with flow-driven selling.

Market relevance

This is a benchmark composition change with a specific effective date, creating near-term, flow-driven trading opportunities and volatility around June 22.

Market effects

Reinforces read-across that AI infrastructure/semiconductor-linked equities are gaining benchmark representation versus traditional IT/software services.

Primarily US-listed index flow effects; may spill into US-listed AI/semis peer group via relative-performance positioning.

Could modestly influence global AI/semis sentiment through benchmark-driven demand, but the mechanism is US index rebalancing.

Alternative perspectives

Index membership changes may be largely mechanical; fundamentals and broader market tape could dominate price action, limiting follow-through beyond the rebalance window.

Liquidity/derivatives hedging around index changes can create short-lived dislocations; also, the article doesn’t quantify expected passive flow size, so actual impact could be smaller than implied.

Key entities

  • Nasdaq-100 quarterly rebalance

    June 11 announcement; effective before market open June 22.

  • Cognizant Technology Solutions

    Removed from Nasdaq-100 effective June 22; stock down ~38% over six months per article.

  • Astera Labs

    Added to Nasdaq-100 effective June 22.

  • CoreWeave

    Added to Nasdaq-100 effective June 22.

Related articles

$RKLBMed

Rocket Lab Bull-Case Target Set at $293 by Morgan Stanley

Morgan Stanley raised its Rocket Lab (RKLB) bull-case price target to $293 from a prior level, keeping an Overweight rating and $105 base case. The bank cited an $8 billion Iridium deal, a $2.20 billion backlog, and Q1 FY26 revenue of $200.35 million (+63.5% YoY), plus defense launch performance. Reaching $293 depends on an on-time Neutron debut and deal milestones.

$RKLBMed

Space Force Awards Two California-based Companies New Launch Provider Contracts

The U.S. Space Force awarded Firm Fixed-Price NSSL Phase 3 Lane 1 launch provider contracts to Impulse Space and Relativity Federal, according to a Space Force press release. Each received a $5 million task order for initial capabilities assessment. The awards add two California-based providers to a lane that already includes Blue Origin, SpaceX, ULA, Rocket Lab, and Stoke Space.

$RKLBMedAI 8/10

Rocket Lab Shares Climb as Wall Street Weighs $8 Billion Iridium Deal, $3.6 Billion Bridge Loan - Rocket

Rocket Lab (RKLB) shares rose as Wall Street weighed its proposed cash-and-stock acquisition of Iridium Communications, valuing Iridium at about $8 billion. Iridium shareholders would receive $27 in cash plus Rocket Lab shares, with both boards approving. Rocket Lab plans a $3.6 billion bridge loan from Deutsche Bank and Wells Fargo. Shares were up 1.42% to $84.53.

$ALABMed

Stock Indexes Fall as Chip Stocks Sink and Crude Soars

Global stocks fell as chip and AI shares dropped after Samsung Electronics’ preliminary earnings missed expectations. WTI crude jumped over 5% after attacks near the Strait of Hormuz and the US revoked an Iran oil waiver. US 10-year yields rose to about 4.535%. Movers included Intel, SOXX, and energy gains in DVN and OXY; Rivian fell on a share sale.